FDA approves Phase II clinical trial of stem cells for Lou Gehrig’s disease (ALS) – Video

Posted: April 19, 2013 at 8:44 am




FDA approves Phase II clinical trial of stem cells for Lou Gehrig #39;s disease (ALS)
Dr. Eva Feldman, U-M neurologist and director of the A. Alfred Taubman Medical Research Institute, discusses the recent FDA approval of a new phase for a cli...

By: UMHealthSystem

Visit link:
FDA approves Phase II clinical trial of stem cells for Lou Gehrig's disease (ALS) - Video

Related Posts